Investors Ride 5 Earnings Rollercoaster Rides

Mylan, Inc. (NASDAQ:MYL) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 19.23% to $0.62 in the quarter versus EPS of $0.52 in the year-earlier quarter. Revenue Rose 2.45% to $1.63 billion from the year-earlier quarter.

Mylan, Inc. reported adjusted EPS income of $0.62 per share. By that measure, the company met the mean analyst estimate of $0.62. It missed the average revenue estimate of $1.69 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MYL

Health Management Associates Inc. (NYSE:HMA) delivered a profit and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased 45.83% to $0.13 in the quarter versus EPS of $0.24 in the year-earlier quarter. Revenue Rose 16.06% to $1.72 billion from the year-earlier quarter.

Health Management Associates Inc. reported adjusted EPS income of $0.13 per share. By that measure, the company missed the mean analyst estimate of $0.15. It beat the average revenue estimate of $1.66 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

HMA

Mettler-Toledo International, Inc. (NYSE:MTD) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 10.84% to $1.84 in the quarter versus EPS of $1.66 in the year-earlier quarter. Revenue Decreased 2.06% to $524.35 million from the year-earlier quarter.

Mettler-Toledo International, Inc. reported adjusted EPS income of $1.84 per share. By that measure, the company beat the mean analyst estimate of $1.8. It missed the average revenue estimate of $534.3 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MTD

Gilead Sciences Inc. (NASDAQ:GILD) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 4.35% to $0.48 in the quarter versus EPS of $0.46 in the year-earlier quarter. Revenue Rose 10.92% to $2.53 billion from the year-earlier quarter.

Gilead Sciences Inc. reported adjusted EPS income of $0.48 per share. By that measure, the company missed the mean analyst estimate of $0.50. It missed the average revenue estimate of $2.58 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

GILD

Celldex Therapeutics, Inc. (NASDAQ:CLDX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.23 in the quarter versus EPS of $-0.27 in the year-earlier quarter. Revenue Decreased 0.82% to $2.41 million from the year-earlier quarter.

Celldex Therapeutics, Inc. reported adjusted EPS loss of $0.23 per share. By that measure, the company missed the mean analyst estimate of $-0.22. It missed the average revenue estimate of $2.42 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CLDX

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.